Acupuncture and Medicare in Australia: Why the Only Dedicated Experts Are Locked Out — and How That Changes

A Policy Puzzle Hidden in Plain Sight

Picture a patient in suburban Brisbane with chronic lower-back pain. They can walk into five different clinics this week and have a needle inserted along the Bladder meridian. Their GP can do it and bulk-bill the visit under the Medicare Benefits Schedule (MBS). Their physiotherapist can do it under a chronic disease management plan, also rebated. Their chiropractor and osteopath can do the same. The remedial massage therapist down the road can offer "dry needling" inside a private health rebate.

The one practitioner the patient cannot see and have any of it touched by Medicare is the registered acupuncturist with a four-year bachelor's degree, AHPRA registration, and several thousand documented clinical hours specifically in acupuncture and Chinese herbal medicine.

This is not an oversight. It is the current state of Australian health policy, and it is worth understanding in full — because it shapes what patients pay, who they see, and how the evidence base for acupuncture is actually being delivered.

Who Can Bill Acupuncture Under Medicare in Australia

Australia's Medicare system reimburses acupuncture through two main streams.

Stream one — medical practitioner items. A small group of MBS items (173, 193, 195, 197 and 199) allows a medical practitioner — a GP or specialist — to perform and claim for acupuncture as part of a consultation. These items have existed since the original MBS was constructed and reflect a 1970s view that acupuncture, where used, would be used by doctors. The Department of Health and Aged Care's MBS online search lists them in full (Department of Health, 2024).

Stream two — chronic disease management allied health items. Under MBS item 10960 and its sibling items, a GP can refer a patient with a chronic condition to up to five allied health visits per calendar year. Eligible providers include physiotherapists, chiropractors, osteopaths, exercise physiologists, podiatrists, dietitians, mental health workers, Aboriginal health practitioners and others. Where the provider's professional scope includes needling — as it does for physiotherapy (dry needling), chiropractic and osteopathy in many practices — the acupuncture or dry needling is delivered under that MBS-funded visit (Department of Health, 2024).

Notice what is not in either list: the registered acupuncturist. The Chinese medicine practitioner. The two professions whose AHPRA-protected titles literally include the word.

How We Got Here

Chinese medicine became a nationally regulated profession in Australia in 2012, when it joined the National Registration and Accreditation Scheme under AHPRA (AHPRA, 2024). That regulatory recognition put Australia ahead of every other Western country at the time. Acupuncturists and Chinese herbalists became one of fifteen regulated health professions, sharing the same legal architecture as nursing, pharmacy and physiotherapy.

Regulation, however, is not reimbursement. The MBS structure had been set decades earlier, and no government — Coalition or Labor — has reopened it to add the newest regulated profession. The result is a strange asymmetry: the federal government considers Chinese medicine practitioners safe and competent enough to be granted protected title and to be held to the same disciplinary standards as a physiotherapist, but not eligible to claim a single Medicare item for the technique they are most qualified to perform.

Training Hours: A Quiet Order-of-Magnitude Gap

This is the part of the story that does not get aired enough. Compare the dedicated acupuncture training of each provider type now permitted to deliver acupuncture under Medicare against that of the registered acupuncturist they are not.

The WHO benchmarks for training in acupuncture (2010) recommend a minimum of 2,000 hours of dedicated training for any practitioner whose primary modality is acupuncture, and around 200 hours for medical practitioners using it as an adjunct (World Health Organization, 2010). Australia's registered acupuncturists comfortably exceed the first standard. Most of the providers currently delivering Medicare-funded needling do not meet the second.

This is not an attack on those professions — physiotherapists, chiropractors and osteopaths bring real clinical strengths and the dry-needling work many of them do is competent and helpful. It is simply an observation that the current Medicare architecture has the depth-of-training pyramid inverted: short-course providers receive public reimbursement, while degree-trained specialists in the same technique do not.

The Evidence Base the Policy Is Failing To Use

The clinical evidence for acupuncture has matured to the point where the policy gap is harder and harder to defend.

The most cited modern synthesis is the individual patient data meta-analysis by Vickers et al. (2018), pooling data from 39 high-quality randomised trials and nearly 21,000 patients. Acupuncture was statistically and clinically superior to both sham and no-acupuncture control for chronic musculoskeletal pain, headache, and osteoarthritis, with effects persisting at 12 months — a profile that compares favourably with most pharmacological options in the same conditions.

The WHO ICD-11 traditional medicine module (2022) gave the world a standardised diagnostic vocabulary for TCM patterns, finally letting health systems code, fund and audit Chinese medicine the same way they code anything else (World Health Organization, 2022). Most OECD countries have moved with this. Australia has not.

The contradiction is sharp. The same federal Department of Health that funds the chronic disease management items pointing patients toward needling delivered by short-course providers also funds the AHPRA structure that registers Chinese medicine practitioners. Two arms of one government produce, between them, an outcome neither would defend if asked to design the system from scratch.

What This Costs Patients

A typical course of treatment for chronic lower-back pain illustrates the practical effect:

• GP-delivered acupuncture under MBS item 193: bulk-billed or low gap, six visits, out-of-pocket often under $50 in total.
• Physiotherapist with dry needling under MBS 10960: five rebated visits per year, gap typically $20–$40 per visit.
• Chiropractor or osteopath with dry needling: same chronic disease management framework, similar gap.
• Registered acupuncturist delivering the same technique with substantially more training hours: full private fee, typically $80–$130 per visit, no Medicare contribution at all.

Patients respond to price. They go where the rebate is, and the system steers them — predictably and at scale — away from the most highly trained provider. It is a textbook example of incentives produced not by clinical evidence but by historical artefact.

The Anomaly Sitting Inside Item 193

Read the descriptor for MBS item 193 closely — the descriptor below is quoted verbatim from MBS Online, Category 1, Group A7 (item start date 1 November 1998, descriptor last updated 1 November 2022) (Department of Health and Aged Care, MBS Online, item 193):

"Professional attendance by a medical practitioner who holds endorsement of registration for acupuncture with the Medical Board of Australia or is registered by the Chinese Medicine Board of Australia as an acupuncturist…"

That is the whole descriptor opening, not a paraphrase. Medicare already names Chinese Medicine Board registration as an acceptable acupuncture credential, and has since the descriptor was last updated in 2022. It is written into the schedule. The catch is the opening clause: the person also has to be a medical practitioner.

So the question that needs answering is not "should Medicare recognise acupuncture?" — it already does, and has for decades. It is not "is CMBA registration a legitimate acupuncture credential?" — the schedule already says it is. The question is narrower and much harder to wave away:

If registration with the Chinese Medicine Board of Australia is an acceptable acupuncture credential for Medicare purposes, why is it not acceptable on its own?

That is a question about provider eligibility for a service the Commonwealth already funds. It is not a request to fund a new kind of care.

What We Are Actually Asking For

Framing decides outcomes. "Recognise acupuncture" invites a debate about evidence, philosophy and worldview that has been running for forty years and will run for forty more. "Extend provider eligibility for an existing funded service to an existing regulated profession" is an administrative question with a defined process behind it.

The ask should be staged, not simultaneous:

Target A — allied health eligibility under GP chronic condition management. Add registered acupuncturists to the list of providers a GP can refer to under the existing individual chronic condition management items (MBS items 10950–10970, plus telehealth items 93000 and 93013). Since 1 July 2025 these sit under a GP chronic condition management plan, which replaced GP management plans and team care arrangements (Department of Health and Aged Care, MBS Note MN.3.1). No new item numbers, no new money outside the existing envelope, no new safety framework. The profession already carries AHPRA registration, accredited qualifications, recency-of-practice and CPD standards, professional indemnity requirements and a public register.

Target B — dedicated MBS items for registered acupuncturists. Only after Target A is bedded down and generating utilisation and outcome data. Target B is a bigger, slower, evidence-hungry process, and attempting it first is how the ask gets shelved.

Sequential, not parallel. Every extra thing bolted onto the first ask lowers its probability of success.

Why Acupuncture Only, And Why First

The initial submission should deliberately exclude Chinese herbal medicine, cupping, gua sha and moxibustion. Not because they lack value — because they widen the evidence surface, the safety assessment and the political target all at once.

Acupuncture is the piece where:

• Medicare already funds the service under existing items.
• The credential is already named in the schedule.
• The comparative-effectiveness literature is deepest.
• The safety profile is best characterised.

A narrow ask can be assessed. A broad ask gets deferred. The rest of the scope can follow once the door is open.

Chronic Pain As The Spearhead

Candidate indications for a first-stage submission — subject to a formal evidence and economic review, not asserted here as settled:

• Chronic low-back pain
• Chronic neck pain
• Osteoarthritis pain (knee, hip)
• Chronic headache and migraine prophylaxis

These are chosen for three reasons: they are conditions where the acupuncture trial literature is strongest (Vickers et al., 2018), where the comparator therapies carry meaningful harms (opioids, long-term NSAIDs, repeat imaging), and where the national cost burden is large enough that a plausible offset argument exists.

Picking indications is a strategic decision, not a clinical one. The clinical work is deciding whether the evidence supports each of them at the standard a health technology assessment applies — which is a higher bar than the standard a clinician applies at the treatment table.

What A Health Technology Assessment Actually Assesses

This is where most advocacy for acupuncture funding falls over. Submissions to the Medical Services Advisory Committee (MSAC) are not judged on efficacy alone. MSAC's terms of reference state that it "appraises medical services, health technologies and health programs for public funding through an assessment of their comparative safety, clinical effectiveness, cost effectiveness and total cost, using the best available evidence" — and that this expressly includes amendments to services already funded on the MBS (MSAC terms of reference). Four criteria, quoted from the source:

1. Comparative safety — against the current standard of care, not against nothing.

2. Clinical effectiveness — magnitude and durability of benefit versus the comparator.

3. Cost effectiveness — an economic evaluation against that comparator.

4. Total cost — the financial implications of funding the service.

MSAC applies a health technology assessment framework built around a PICO (population, intervention, comparator, outcome), an assessment report covering clinical evidence plus economic and financial evaluation, an independent critique, and stakeholder consultation. Applications run a pre-assessment phase (suitability, PICO confirmation, PASC) and an assessment phase (ESC, then MSAC) (MSAC process).

An argument built only on pillar two fails. A four-pillar dossier needs a health economist as much as it needs a systematic reviewer, and the economic modelling is usually the part nobody has funded.

The offset argument — that funded acupuncture displaces some proportion of opioid prescriptions, imaging, injections and surgical consults in chronic pain — is plausible and is exactly the kind of claim that has to be modelled rather than asserted.

A Pilot, Not A Blank Cheque

The most fundable version of this ask is a time-limited, evaluated pilot rather than an open-ended schedule change:

• Duration: three years.
• Access: GP referral required, mirroring the existing chronic-condition pathway.
• Volume cap: five services per patient per calendar year, matching the current cap on individual chronic condition management health services (MBS Note MN.3.1).
• Defined indications: the chronic pain shortlist above, not "any condition".
• Mandatory outcome collection: standardised, pre-specified measures at baseline, end of course and follow-up.
• Independent evaluation built into the design and funded from the outset.

A pilot converts an open-ended fiscal risk into a bounded, measurable one — and it produces the Australian utilisation and outcome data that any Target B submission will need anyway.

The Workforce And The Regulator Already Exist

The usual objection to extending eligibility to a new provider group is administrative novelty: who accredits them, who registers them, who handles complaints, who sets CPD, who carries indemnity.

For registered acupuncturists, all of that already exists and has since 2012. There is a national board, accredited entry qualifications, registration standards, a public register, mandatory CPD, mandatory indemnity, and a national complaints and disciplinary process. Current registrant numbers are published by the Chinese Medicine Board of Australia each quarter (Chinese Medicine Board of Australia registration data); this article deliberately quotes no headline registrant figure, because the number moves every quarter and the current report should be read directly.

There is no new machinery to build. That is the cheapest sentence in the whole submission.

What Would A Sensible Reform Look Like

With the staging above in place, the reform reduces to three moves in order.

1. Extend the chronic-condition allied health item list to registered acupuncturists (Target A). Smallest change, largest patient benefit, no new item numbers — it extends an existing item to a regulated profession that already meets the safety, training and accreditation thresholds applied to every other allied health provider on the list.

2. Align provider eligibility with WHO training benchmarks. Any provider performing acupuncture under a Medicare item should meet the WHO 2010 minimum hours appropriate to their scope — 200 hours for adjunctive use, 2,000 hours for primary-modality use (World Health Organization, 2010). A quality-of-care floor, not a turf claim.

3. Recognise ICD-11 Module 26 in MBS coding (World Health Organization, 2022), so traditional medicine utilisation can finally be counted the same way everything else is — a precondition for the evidence base any Target B submission will rest on.

None of this displaces a single existing provider, and none of it requires funding outside the existing chronic disease management envelope. It corrects an asymmetry that has been quietly costing Australian patients access and choice for a decade and a half.

Source List — Claim By Claim

Every policy claim in the sections above traces to a primary source. Verified 14 August 2026.

Two things this article deliberately does not state, because they could not be confirmed against a primary source at the time of writing: any specific MSAC application lodgement deadline, and any exact current registrant count. Both change on a cycle — check the MSAC and Chinese Medicine Board pages directly rather than relying on a figure quoted anywhere, including here.

What Practitioners Can Do In The Meantime

Until the reform comes — and the politics suggest it will not come quickly — the practical playbook for the registered acupuncture profession is straightforward.

• Document outcomes with the same rigour as any other allied health provider. The eventual policy case will be won by data, not advocacy alone.
• Use validated outcome measures in every clinical record so that audits and integrative referral conversations have a shared language.
• Engage with GPs at the referral interface. The chronic disease management item is gated by a GP plan; relationships with referring doctors are the practical workaround within the current system.
• Make the training-hours story visible to patients. Most patients have no idea that the practitioner without the rebate is the one with five times the dedicated training. They deserve to.

The Chinese medicine profession in Australia did the hard work of national regulation in 2012 and has been quietly delivering safe, evidence-aligned care ever since. The next step — equal access to the public reimbursement system that already funds the same technique delivered by less-trained providers — is overdue.

Related Reading

• WorkCover Acupuncture Australia — How the workers-compensation system already recognises acupuncturists, and what Medicare can learn from it
• AI TCM Diagnosis Tool — Tools that help registered practitioners deliver and document care to allied-health-equivalent standards
• TCM Pattern Differentiation Software — Outcome-measure and pattern-tracking workflow for integrative referral